Cognitive impairment and BDNF serum levels

Area of Science:

• Neuroscience
• Biochemistry

Background:

• Brain-derived neurotrophic factor (BDNF) plays a crucial role in neuronal survival and function.
• Alterations in BDNF levels are implicated in various neurodegenerative diseases and cognitive impairments.

Purpose of the Study:

• To investigate the relationship between serum BDNF levels and the intensity of cognitive impairment.
• To examine BDNF serum levels across different neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease.

Main Methods:

• Serum BDNF levels were quantified using an ELISA kit in 378 participants.
• Participants included Alzheimer's disease patients, mild cognitive impairment patients, Parkinson's disease patients, and cognitively normal controls.

Main Results:

• Alzheimer's disease patients exhibited significantly lower serum BDNF levels compared to all control groups (MCI, CN, ND).
• BDNF serum levels showed a significant negative correlation with the severity of cognitive impairment.
• Advanced age and lower educational attainment were associated with decreased BDNF levels, independent of diagnosis.

Conclusions:

• Decreased serum BDNF levels are indicative of cognitive impairment severity, particularly in Alzheimer's disease.
• Age and education are significant factors influencing BDNF levels in neurodegenerative disease contexts.
• Serum BDNF levels do not appear to correlate with depressive symptoms in the studied populations.